Cytiva Sera-Xtracta Virus/Pathogen Kit

Description

• Sera-Xtracta Virus/Pathogen Kit for high-throughput total nucleic acid (DNA/RNA) isolation from bacteria and viruses including Adenovirus (Type 14), Influenza A (H3N2) and COVID-19
• Offers the advantages of solid phase extraction (using magnetic beads) and reproducible yields
• Simplified protocol can be adapted for both manual and automated high-throughput processing
• Scalable up to 400 μL of sample
• Rapid extraction procedure can be completed in less than 30 minutes
• For use with respiratory biological matrices, blood and universal transport media to support the sensitive downstream detection of viruses and other pathogens found in low concentrations
• Compatible with molecular biology techniques, including quantitative polymerase chain reaction (qPCR, RT-qPCR), droplet digital PCR (ddPCR), and next-generation sequencing (NGS)
• Sera-Xtracta Virus/Pathogen Kit provides a simple and rapid method to optimize the workflow for sensitive detection system for viruses and other pathogens found in low concentrations
• Optimize isolation workflows to reduce bottlenecks To address this bottleneck, our robust extraction chemistry ensures that the total nucleic acid is selectively bound to the superparamagnetic beads, while impurities are efficiently removed during the quick wash steps
• The resulting high quality total nucleic acid is then eluted from the bead using a suitable elution buffer of choice
• The rapid Sera-Xtracta workflow gives pure, high-quality nucleic acid suitable for sensitive molecular testing
• Infectious diseases affect millions of people every year
• Particularly virulent and multi-drug resistant agents are increasingly responsible for infections with ever-expanding complexities
• The design, manufacture and validation of assays for these pathogenic agents requires the successful purification of high-quality nucleic acid
• This is essential to any molecular research and testing workflow
• The nucleic acid purification process can be a bottleneck because sufficient nucleic acid from biological samples is required to meet a sensitivity threshold for assays which are designed to help identify, map or make informed decisions on latent and active infections.